Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids

J Lipid Res. 2020 Aug;61(8):1203-1220. doi: 10.1194/jlr.RA120000781. Epub 2020 Jun 2.

Abstract

Angiopoietin-like protein (ANGPTL)8 has been implicated in metabolic syndrome and reported to regulate adipose FA uptake through unknown mechanisms. Here, we studied how complex formation of ANGPTL8 with ANGPTL3 or ANGPTL4 varies with feeding to regulate LPL. In human serum, ANGPTL3/8 and ANGPTL4/8 complexes both increased postprandially, correlated negatively with HDL, and correlated positively with all other metabolic syndrome markers. ANGPTL3/8 also correlated positively with LDL-C and blocked LPL-facilitated hepatocyte VLDL-C uptake. LPL-inhibitory activity of ANGPTL3/8 was >100-fold more potent than that of ANGPTL3, and LPL-inhibitory activity of ANGPTL4/8 was >100-fold less potent than that of ANGPTL4. Quantitative analyses of inhibitory activities and competition experiments among the complexes suggested a model in which localized ANGPTL4/8 blocks the LPL-inhibitory activity of both circulating ANGPTL3/8 and localized ANGPTL4, allowing lipid sequestration into fat rather than muscle during the fed state. Supporting this model, insulin increased ANGPTL3/8 secretion from hepatocytes and ANGPTL4/8 secretion from adipocytes. These results suggest that low ANGPTL8 levels during fasting enable ANGPTL4-mediated LPL inhibition in fat tissue to minimize adipose FA uptake. During feeding, increased ANGPTL8 increases ANGPTL3 inhibition of LPL in muscle via circulating ANGPTL3/8, while decreasing ANGPTL4 inhibition of LPL in adipose tissue through localized ANGPTL4/8, thereby increasing FA uptake into adipose tissue. Excessive caloric intake may shift this system toward the latter conditions, possibly predisposing to metabolic syndrome.

Keywords: adipose tissue; angiopoietin-like protein 3; angiopoietin-like protein 4; lipid metabolism; lipoprotein lipase; metabolic syndrome; muscle; obesity; postprandial condition; triglycerides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiopoietin-Like Protein 3
  • Angiopoietin-Like Protein 4 / metabolism*
  • Angiopoietin-Like Protein 8
  • Angiopoietin-like Proteins / metabolism*
  • Biomarkers / metabolism
  • Fatty Acids / metabolism*
  • Humans
  • Peptide Hormones / metabolism*
  • Postprandial Period*

Substances

  • ANGPTL3 protein, human
  • ANGPTL8 protein, human
  • Angiopoietin-Like Protein 3
  • Angiopoietin-Like Protein 4
  • Angiopoietin-Like Protein 8
  • Angiopoietin-like Proteins
  • Biomarkers
  • Fatty Acids
  • Peptide Hormones